Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
2016 · Leukemia · 239 citations
https://doi.org/10.1038/leu.2016.360
M
Mette Ilander
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
88
Papers
1.2K
Citations
19
h-index
23
i10-index
Mette Ilander is an academic researcher from University of Helsinki. The author has contributed to research in topics: Chronic Myeloid Leukemia Treatments & Chronic Lymphocytic Leukemia Research & Immune Cell Function and Interaction. The author has an h-index of 19, co-authored 75 publications.
ORCID: 0000-0001-9387-1179Papers by this author
worksSingle-cell characterization of anti–LAG-3 and anti–PD-1 combination treatment in patients with melanoma
2023 · Journal of Clinical Investigation · 91 citations
https://doi.org/10.1172/jci164809
Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy
2019 · Nature Communications · 79 citations
https://doi.org/10.1038/s41467-019-08541-2
Combined immunodeficiency and hypoglycemia associated with mutations in hypoxia upregulated 1
2016 · Journal of Allergy and Clinical Immunology · 20 citations
https://doi.org/10.1016/j.jaci.2016.09.050
Publisher Correction: Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy
2019 · Nature Communications · 1 citations
https://doi.org/10.1038/s41467-019-08956-x
Additional file 1: of Immune cell phenotype and functional defects in Netherton syndrome
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7386140
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat